stockrowBioNexus Gene Lab Corp.
BGLCBasic Materials Specialty Chemicals
BioNexus Gene Lab Corp.’s revenue for fiscal 2025 (year ended December 2025) was $7.4 million, down 21.9% from fiscal 2024.
- Revenue
- −96.6%
- EPS
- +64.7%
- Free cash flow
- +44.3%
Quarter to June 2026, against a year earlier
Follow BGLC
Alert me
BioNexus Gene Lab Corp. (BGLC) EV/Sales
As of 6 November 2026, BioNexus Gene Lab Corp. (BGLC) trades at a EV/Sales of −0.5×. Over the past ten years it has ranged from −0.5× (November 2026) to 198× (September 2022) — the current reading is the lowest in ten years. That is below the Specialty Chemicals industry median of 1.9× and below the Basic Materials sector median of 1.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.5× | 507.97% |
| FY2024 | 0.1× | (99.05%) |
| FY2023 | 7.9× | (49.56%) |
| FY2022 | 15.6× | (42.37%) |
| FY2021 | 27.1× | 32.10% |
| FY2020 | 20.5× | 110.76% |
| FY2019 | 9.7× | 0.00% |
| FY2018 | 9.7× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.4× | 67.61% |
| Mar 2026 | 0.2× | (48.41%) |
| Dec 2025 | 0.5× | (38.43%) |
| Sep 2025 | 0.7× | 177.22% |
| 29 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| BGLC BioNexus Gene Lab Corp. | −0.5× |
| BON Bon Natural Life Limited compare | −0.1× |
| YMAT J-Star Holding Co., Ltd compare | n/m |
| FEAM 5E Advanced Materials, Inc. compare | n/m |
| SNES Senestech, Inc. compare | 0.4× |
| CNEY CN Energy Group. Inc. compare | 0.5× |
| NTIC Northern Technologies International Corporation compare | 0.9× |
| LOOP Loop Industries, Inc. compare | 27.9× |
| CITR CitroTech Inc. compare | 38.0× |
| Specialty Chemicals industry median | 1.9× |
| Basic Materials sector median | 1.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)